For nearly 30 years, DCRI Think Tanks have aimed to address the most critical gaps in clinical research by convening leaders across the healthcare industry to map the way forward in designing, conducting, and implementing high-quality, evidence-based research. This summer’s program will focus on improving clinical trial efficiencies and is designed to harness the creativity and expertise of our community to identify scalable, impactful solutions that can streamline clinical trial operations.
The DCRI Think Tank team is excited to announce the criteria for submitting innovative ideas that aim to improve clinical trial efficiencies, with a focus on operational efficiencies. By participating, you will have the opportunity to shape the future of clinical research, contribute to more patient-centric and compliant trial designs, and help reduce the time and cost associated with bringing new therapies to market.
Selected submissions will be invited to a virtual session with pharmaceutical leadership to present and discuss their ideas – an excellent opportunity to gain visibility, receive expert feedback, and potentially influence strategic direction.
Submission Criteria
- Innovation aimed at improving operational aspects of clinical trial management.
- Detail how innovation will impact or enhance operational efficiencies.
- Detail stakeholder engagement – patients, regulatory agencies, industry sponsors - with an emphasis on improving patient experience and engagement.
Considerations
- Innovation should be scalable across different types and phases of clinical trials and adaptable to various therapeutic areas.
- Submissions should consider regulatory requirements and demonstrate how they align with or enhance compliance.
- Submissions should consider the most efficient use of resources to ensure that innovation is both cost-effective and sustainable.
- Product/efficiency intended for use by pharmaceutical companies.
- Ideas and innovations do not have to be product-ready, but please include information regarding your path to creating a viable and commercially viable product.
The deadline for submissions is June 23, 2025.
We encourage you to submit your innovative ideas and participate in this exciting initiative to improve our clinical trial processes. Please ensure that your submissions adhere to the criteria outlined above.